Saturday, September 12, 2015 12:11:39 PM
North, I begin to see the bigger picture more clearly and Hedge Funds don't just shut down without any reason at all and labs just don't shut down for no reason at all either. Nice to see the Thorpe lab picked up by Dr. Rolf Brekken immediately and there was NO hold back like those gov't inspired molasses you spoke of : )
-----------------------------------------------------------
The basic research Laboratory of Structural Enzymology and Biochemistry have to thread protein biochemistry, which was enriched in the 90 structural biology and biophysics and biology and cellular imaging since the 2000. the laboratory has led to today renowned research on the molecular mechanisms that govern major cellular processes in normal and diseased cell, including the dynamics of the cytoskeleton, membrane trafficking and cell protéostase.
Founded in 1960 by Professor Georges Cohen at the request of Jacques Monod in order to develop research and enzymology allostery, the lab closed December 31, 2014. A reception was held 12 December 2014 on the occasion, in the presence of Professor Cohen and many current and former staff of LEBS.
-----------------------------------------------------------
Working with Jacques Monod and Georges Cohen
François Jacob Scientist
"...it was very difficult for some to keep up"
http://www.webofstories.com/play/francois.jacob/38;jsessionid=C092248E4CB83436F0DECCCC6A9C4F56
------------------------------------------------------------
Phosphatidylserine synthesis required for the maximal tryptophan transport activity in Saccharomyces cerevisiae.
http://www.ncbi.nlm.nih.gov/pubmed/10705462
-----------------------------------------------------------
Messenger RNA:
...ribosomes could join any messenger RNA with added Magnesium
http://www.webofstories.com/play/francois.jacob/40
-----------------------------------------------------------
of course... after hearing the above re: magnesium, I instantly think of this publication:
Effect of calcium and magnesium on phosphatidylserine membranes: experiments and all-atomic simulations.
http://www.ncbi.nlm.nih.gov/pubmed/22824273
----------------------------------------------------------
George N Cohen: mentor ..Jacques Monod
http://www.annualreviews.org/doi/pdf/10.1146/annurev.micro.59.030804.121329
-----------------------------------------------------------
on a tangent sidenote:
Bristol Myers Squibb and Pfizer were aligned on OX40 patents
Binding molecules to the human OX40 receptor
http://www.google.com/patents/US7960515
... and they were even trying to improve on all that toxic chemotherapy:
Preparative immunotherapy with anti-OX40 and
anti-CTLA4 improves the response to
chemotherapy
http://paperity.org/p/56220135/preparative-immunotherapy-with-anti-ox40-and-anti-ctla4-improves-the-response-to
----------------------------------------------------------
The puzzle pieces grow like algae by the day and not to go off on another tangent, but I did point out PS+Algae many months ago, because YES... ALGAE contains flipped PS as well !!
Part I:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=104763593
Part II:
ExxonMobil (XOM) is spending $600 million on a 10-year effort to turn algae into oil. And Royal Dutch Shell (RDS/A) has invested billions of dollars in a Brazilian biofuels venture, buying up sugar cane mills, plantations, and refineries to make ethanol.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=104768333
.... once some BTD's, partnering news, Sunrise news..etc is allowed to surface, maybe some of those 175 Million shares can be sold and allow Peregrine enough breathing room to dig deeper into PS Targeting beyond oncology/viral..etc.
Hopefully you're still reading North4000, because I completely forgot this post all started by you asking about where C1q was found and it looks to being hidden, except the early years when this was made public
C1q binds phosphatidylserine....
http://www.ncbi.nlm.nih.gov/pubmed/18250442
-----------------------------------------------------------
The basic research Laboratory of Structural Enzymology and Biochemistry have to thread protein biochemistry, which was enriched in the 90 structural biology and biophysics and biology and cellular imaging since the 2000. the laboratory has led to today renowned research on the molecular mechanisms that govern major cellular processes in normal and diseased cell, including the dynamics of the cytoskeleton, membrane trafficking and cell protéostase.
Founded in 1960 by Professor Georges Cohen at the request of Jacques Monod in order to develop research and enzymology allostery, the lab closed December 31, 2014. A reception was held 12 December 2014 on the occasion, in the presence of Professor Cohen and many current and former staff of LEBS.
-----------------------------------------------------------
Working with Jacques Monod and Georges Cohen
François Jacob Scientist
"...it was very difficult for some to keep up"
http://www.webofstories.com/play/francois.jacob/38;jsessionid=C092248E4CB83436F0DECCCC6A9C4F56
------------------------------------------------------------
Phosphatidylserine synthesis required for the maximal tryptophan transport activity in Saccharomyces cerevisiae.
http://www.ncbi.nlm.nih.gov/pubmed/10705462
-----------------------------------------------------------
Messenger RNA:
...ribosomes could join any messenger RNA with added Magnesium
http://www.webofstories.com/play/francois.jacob/40
-----------------------------------------------------------
of course... after hearing the above re: magnesium, I instantly think of this publication:
Effect of calcium and magnesium on phosphatidylserine membranes: experiments and all-atomic simulations.
http://www.ncbi.nlm.nih.gov/pubmed/22824273
----------------------------------------------------------
George N Cohen: mentor ..Jacques Monod
http://www.annualreviews.org/doi/pdf/10.1146/annurev.micro.59.030804.121329
-----------------------------------------------------------
on a tangent sidenote:
Bristol Myers Squibb and Pfizer were aligned on OX40 patents
Binding molecules to the human OX40 receptor
http://www.google.com/patents/US7960515
... and they were even trying to improve on all that toxic chemotherapy:
Preparative immunotherapy with anti-OX40 and
anti-CTLA4 improves the response to
chemotherapy
http://paperity.org/p/56220135/preparative-immunotherapy-with-anti-ox40-and-anti-ctla4-improves-the-response-to
----------------------------------------------------------
The puzzle pieces grow like algae by the day and not to go off on another tangent, but I did point out PS+Algae many months ago, because YES... ALGAE contains flipped PS as well !!
Part I:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=104763593
Part II:
ExxonMobil (XOM) is spending $600 million on a 10-year effort to turn algae into oil. And Royal Dutch Shell (RDS/A) has invested billions of dollars in a Brazilian biofuels venture, buying up sugar cane mills, plantations, and refineries to make ethanol.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=104768333
.... once some BTD's, partnering news, Sunrise news..etc is allowed to surface, maybe some of those 175 Million shares can be sold and allow Peregrine enough breathing room to dig deeper into PS Targeting beyond oncology/viral..etc.
Hopefully you're still reading North4000, because I completely forgot this post all started by you asking about where C1q was found and it looks to being hidden, except the early years when this was made public
C1q binds phosphatidylserine....
http://www.ncbi.nlm.nih.gov/pubmed/18250442
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
